Duality Biotherapeutics Plans RMB 6.75bn Shanghai Listing; PKO Bank Hipoteczny Final Terms
Duality Biotherapeutics is pursuing a Rmb6.75 billion listing on the Shanghai Stock Exchange to accelerate its development of next-generation antibody-drug conjugates (ADCs). This strategic move signals China’s intent to dominate ... Read More